These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 29074425)

  • 1. The membrane bile acid receptor TGR5 drives cell growth and migration via activation of the JAK2/STAT3 signaling pathway in non-small cell lung cancer.
    Liu X; Chen B; You W; Xue S; Qin H; Jiang H
    Cancer Lett; 2018 Jan; 412():194-207. PubMed ID: 29074425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physalin A exerts anti-tumor activity in non-small cell lung cancer cell lines by suppressing JAK/STAT3 signaling.
    Zhu F; Dai C; Fu Y; Loo JF; Xia D; Gao SP; Ma Z; Chen Z
    Oncotarget; 2016 Feb; 7(8):9462-76. PubMed ID: 26843613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aryl hydrocarbon receptor mediates Jak2/STAT3 signaling for non-small cell lung cancer stem cell maintenance.
    Xiong J; Zhang X; Zhang Y; Wu B; Fang L; Wang N; Yi H; Chang N; Chen L; Zhang J
    Exp Cell Res; 2020 Nov; 396(1):112288. PubMed ID: 32941808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of JAK2/STAT3 signaling pathway on angiogenesis in non-small cell lung cancer].
    Zhao M; Liu F; Wang JY; Zhang WY; Gao FH; Jiang B
    Zhonghua Yi Xue Za Zhi; 2011 Feb; 91(6):375-81. PubMed ID: 21418908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. XCR1 promotes cell growth and migration and is correlated with bone metastasis in non-small cell lung cancer.
    Wang T; Han S; Wu Z; Han Z; Yan W; Liu T; Wei H; Song D; Zhou W; Yang X; Xiao J
    Biochem Biophys Res Commun; 2015 Aug; 464(2):635-41. PubMed ID: 26166822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feed-Forward Reciprocal Activation of PAFR and STAT3 Regulates Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer.
    Chen J; Lan T; Zhang W; Dong L; Kang N; Zhang S; Fu M; Liu B; Liu K; Zhan Q
    Cancer Res; 2015 Oct; 75(19):4198-210. PubMed ID: 26359459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The G-protein-coupled bile acid receptor Gpbar1 (TGR5) suppresses gastric cancer cell proliferation and migration through antagonizing STAT3 signaling pathway.
    Guo C; Su J; Li Z; Xiao R; Wen J; Li Y; Zhang M; Zhang X; Yu D; Huang W; Chen WD; Wang YD
    Oncotarget; 2015 Oct; 6(33):34402-13. PubMed ID: 26417930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AKR1C1 Activates STAT3 to Promote the Metastasis of Non-Small Cell Lung Cancer.
    Zhu H; Chang LL; Yan FJ; Hu Y; Zeng CM; Zhou TY; Yuan T; Ying MD; Cao J; He QJ; Yang B
    Theranostics; 2018; 8(3):676-692. PubMed ID: 29344298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JAK2/STAT3 signaling pathway activation mediates tumor angiogenesis by upregulation of VEGF and bFGF in non-small-cell lung cancer.
    Zhao M; Gao FH; Wang JY; Liu F; Yuan HH; Zhang WY; Jiang B
    Lung Cancer; 2011 Sep; 73(3):366-74. PubMed ID: 21333372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-X-C chemokine receptor 2 correlates with unfavorable prognosis and facilitates malignant cell activities via activating JAK2/STAT3 pathway in non-small cell lung cancer.
    Wei L; Liu Y; Ma Y; Ding C; Zhang H; Lu Z; Gu Z; Zhu C
    Cell Cycle; 2019 Dec; 18(24):3456-3471. PubMed ID: 31731888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autophagy inhibition potentiates the anti-angiogenic property of multikinase inhibitor anlotinib through JAK2/STAT3/VEGFA signaling in non-small cell lung cancer cells.
    Liang L; Hui K; Hu C; Wen Y; Yang S; Zhu P; Wang L; Xia Y; Qiao Y; Sun W; Fei J; Chen T; Zhao F; Yang B; Jiang X
    J Exp Clin Cancer Res; 2019 Feb; 38(1):71. PubMed ID: 30755242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stem cells enhance lung cancer initiation through activation of IL-6/JAK2/STAT3 pathway.
    Hsu HS; Lin JH; Hsu TW; Su K; Wang CW; Yang KY; Chiou SH; Hung SC
    Lung Cancer; 2012 Feb; 75(2):167-77. PubMed ID: 21802163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Major vault protein suppresses lung cancer cell proliferation by inhibiting STAT3 signaling pathway.
    Bai H; Wang C; Qi Y; Xu J; Li N; Chen L; Jiang B; Zhu X; Zhang H; Li X; Yang Q; Ma J; Xu Y; Ben J; Chen Q
    BMC Cancer; 2019 May; 19(1):454. PubMed ID: 31092229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Farnesoid X receptor promotes non-small cell lung cancer metastasis by activating Jak2/STAT3 signaling via transactivation of IL-6ST and IL-6 genes.
    Jin X; Shang B; Wang J; Sun J; Li J; Liang B; Wang X; Su L; You W; Jiang S
    Cell Death Dis; 2024 Feb; 15(2):148. PubMed ID: 38360812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HES5 promotes cellular proliferation of non-small cell lung cancer through STAT3 signaling.
    Gu S; Zhang R; Gu J; Li X; Lv L; Jiang J; Xu Z; Wang S; Shi C; Wang DP; Wu C
    Oncol Rep; 2017 Jan; 37(1):474-482. PubMed ID: 27878283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eriocalyxin B blocks human SW1116 colon cancer cell proliferation, migration, invasion, cell cycle progression and angiogenesis via the JAK2/STAT3 signaling pathway.
    Lu YM; Chen W; Zhu JS; Chen WX; Chen NW
    Mol Med Rep; 2016 Mar; 13(3):2235-40. PubMed ID: 26795301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Akt1/IL-6/STAT3 pathway regulates growth of lung tumor initiating cells.
    Malanga D; De Marco C; Guerriero I; Colelli F; Rinaldo N; Scrima M; Mirante T; De Vitis C; Zoppoli P; Ceccarelli M; Riccardi M; Ravo M; Weisz A; Federico A; Franco R; Rocco G; Mancini R; Rizzuto A; Gulletta E; Ciliberto G; Viglietto G
    Oncotarget; 2015 Dec; 6(40):42667-86. PubMed ID: 26486080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reciprocal activation of α5-nAChR and STAT3 in nicotine-induced human lung cancer cell proliferation.
    Zhang Y; Jia Y; Li P; Li H; Xiao D; Wang Y; Ma X
    J Genet Genomics; 2017 Jul; 44(7):355-362. PubMed ID: 28750889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deficiency of G-protein-coupled bile acid receptor Gpbar1 (TGR5) enhances chemically induced liver carcinogenesis.
    Chen WD; Yu D; Forman BM; Huang W; Wang YD
    Hepatology; 2013 Feb; 57(2):656-66. PubMed ID: 22911633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoglobulin-like transcript 4 promotes tumor progression and metastasis and up-regulates VEGF-C expression via ERK signaling pathway in non-small cell lung cancer.
    Zhang P; Guo X; Li J; Yu S; Wang L; Jiang G; Yang D; Wei Z; Zhang N; Liu J; Sun Y
    Oncotarget; 2015 May; 6(15):13550-63. PubMed ID: 25948790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.